Europe Infusion Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.

The Europe infusion devices market size is expected to reach US$ 6,590.36 million by 2031 from US$ 4,047.05 million in 2023. The market is estimated to record a CAGR of 6.3% from 2023 to 2031. 

Executive Summary and Europe Infusion Devices Market Analysis:

The Europe infusion devices market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. The market in Europe is expected to grow owing to the rising adoption of infusion devices such as infusion pumps for the treatment of chronic diseases such as cancer, diabetes, and circulatory diseases. In addition, strategic developments, including geographical expansion by market players operating in the region, are contributing to the growth of the Europe infusion devices market. For instance, in January 2024, Medtronic plc, a leading global medical technology company, announced CE Mark approval for the MiniMed 780G insulin pump system with Simplera Sync, a disposable continuous glucose monitor (CGM). It was made available in Europe through a limited release in summer of 2024. 

Europe Infusion Devices Market Strategic Insights

Get more information on this report Request Free Sample PDF

Europe Infusion Devices Market Segmentation Analysis

Key segments that contributed to the derivation of the Europe infusion devices market analysis are product type, infusion pumps, infusion sets, application, and end user.

• By product type, the Europe infusion devices market is bifurcated into infusion pumps and infusion sets. The infusion pumps held a larger share of the market in 2023.
• In terms of infusion pumps, the market is segmented into volumetric pumps, syringe pumps, insulin pumps, patient control analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps. The volumetric pumps segment held the largest share of the market in 2023.
• By infusion sets, the Europe infusion devices market is bifurcated into vented infusion sets and non-vented infusion sets. The vented infusion sets held a larger share of the market in 2023.
• By application, the Europe infusion devices market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and other. The diabetes held the largest share of the market in 2023
• By end user, the Europe infusion devices market is segmented into hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others. The hospitals and specialty clinics held the largest share of the market in 2023.

Europe Infusion Devices Market Outlook

Advancements in healthcare are increasing life expectancy globally, leading to a global rise in the geriatric population. As per the WHO, by 2030, one in 6 people in the world will be 60 years or more. One billion people were reported to be 60 and above in 2020 and the number is expected to reach 1.4 billion in 2030 and 2.1 billion by 2050. WHO also stated that by 2050, 80% of older people will be living in low- and middle-income countries. Additionally, as per the Population Reference Bureau, Asia and Europe have the oldest population. Japan ranks first with 28% of geriatric population, followed by Italy with 23%. Finland, Portugal, and Greece are among the top five countries with ~22% of geriatric population. A few key benefits of infusion therapy used for geriatric populations are listed below-

Rehydration and Electrolyte Balance: Dehydration can be a higher risk for older people due to factors such as decreased urge to drink fluids, certain medications, and changes in kidney function. IV fluids help seniors maintain the necessary hydration and electrolyte levels for overall health.

Improved Nutritional Status: Consumption and absorption of the required nutrient become challenging with age, increasing the risk of chronic illnesses. Infusion therapy provides essential minerals, vitamins, and amino acids efficiently into the bloodstream and eases the process of nutrient uptake.

Enhanced Immune Function: Immune systems need extra support at an older age as they become more vulnerable to infections. Infusion therapy can deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly to the body.

Pain Management: The senior population majorly suffers from chronic pain, affecting their quality of life. Infusion therapy can quickly and effectively manage pain by delivering medication directly into the bloodstream, reducing inflammation and providing relief.

Thus, the increasing geriatric population drives the demand for infusion devices across the globe.

Europe Infusion Devices Market Country Insights

Based on country, the Europe infusion devices market comprises Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2023.

The prevalence of chronic disorders such as cancer and diabetes is increasing in Germany. According to the IDF Diabetes Atlas statistics published in 2021, 6.12 million people in Germany had diabetes in 2021. This number is expected to increase to 6.5 million by 2030. As per the surveillance report published by Robert Koch Institute in 2023, from 2014 to 2022, the use of insulin pump therapy among children and adolescents with type 1 diabetes in Germany significantly increased. In 2022, 63.7% of children and adolescents used an insulin pump, with 66.6% of the girl's population and 61.3% of the boy's population using it. Therefore, the growing prevalence of chronic diseases such as diabetes brings opportunities for market players to launch innovations, such as infusion pumps, in the country.

Europe Infusion Devices Market Report Highlights

Europe Infusion Devices Market Company Profiles

Some of the key players operating in the market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Infusion Devices Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Europe Infusion Devices Market Country and Regional Insights